Home
Resources
...
Success Stories
Success Stories
Success Stories
Follow portfolio news

Interview Jeff Wessler - CEO Heartbeat

Published on
25/11/2025
15:43mn
The subtitles for this video were generated automatically using artificial intelligence.

Summary

The story of Heartbeat Health perfectly illustrates the convergence of medical innovation, entrepreneurship, and private equity. Founded by Jeffrey Wessler, a trained cardiologist, the company was born out of a simple yet critical observation: the healthcare system treats cardiovascular diseases too late, even though the technologies exist to intervene earlier. Leaving academia, he chose to create a virtual cardiology solution capable of taking proactive action on a large scale. Heartbeat offers an innovative care model based on telemedicine, combining remote consultations, digital diagnostics, and personalized follow-up. The goal is clear: to improve medical outcomes while reducing hospitalizations. Success has followed, with over one million patients supported and compelling clinical results, notably a significant reduction in rehospitalizations, validated by a published scientific study. The company’s development has been part of a demanding entrepreneurial journey, marked by significant personal and professional challenges. The role of CEO, assumed by the founder, has been crucial in structuring the company and driving its long-term vision. The entry of the Cressey private equity fund marks a strategic turning point. Beyond financing, this partnership brings sector-specific expertise, operational support, and comprehensive corporate structuring. This support has enabled Heartbeat to accelerate its growth, achieve profitability, and strengthen its business model. This case illustrates the key role of private equity in the development of innovative companies: providing financial resources, as well as strategic, human, and operational support. The partnership is based on a collaborative approach, where the investor acts as a true catalyst for growth. Going forward, the challenge for Heartbeat will be to scale up while maintaining a high level of excellence, particularly in terms of quality of care and the scientific validation of its model. This constant commitment is at the heart of its strategy and will determine its long-term success.

Other episodes in the series

Explore our content collections, which bring together different formats around a single subject/issue/theme.
No articles in this category yet.
Welcome to Altaroc
To provide you with a tailored experience, please complete your profile.
Please fill out your profile to access the site
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
YOUR INVESTOR PROFILE
Financial intermediary or professional investor
Financial advisors, wealth managers, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced investor or Altaroc investor
Private investors who have already invested with Altaroc or who have a minimum investment capacity of €100,000.
Private investors who have previously invested in Altaroc who have a minimum investment capacity of 200,000 euros.
Non-professional (retail) investor
Individual investors with an investment capacity below €100,000.
Retail investors with an investment capacity of less than 200,000 euros.
Institutional investor
Pension funds, retirement schemes, asset management companies, and single-family offices.
Select your language and investor profile to continue
Select your investor profile to continue
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.